Alex Van Belkum

Alex Van Belkum

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
OVOlivier Vandenberg
Olivier Vandenberg
DMDelphine Martiny
Delphine Martiny
OROlivier Rochas
Olivier Rochas
ABAlex Van Belkum
Alex Van Belkum
ZKZisis Kozlakidis
Zisis Kozlakidis

1 June 1998 in Microbiology and Molecular Biology Reviews
Verified
Journal Article
Closed access
PDF file
ABAlex Van Belkum
Alex Van Belkum
SSStewart Scherer
Stewart Scherer
LALoek van Alphen
Loek van Alphen
HVHenri Verbrugh
Henri Verbrugh
SUMMARY: Short-sequence DNA repeat (SSR) loci can be identified in all eukaryotic and many prokaryotic genomes. These loci harbor short or long stretches of repeated nucleotide sequence motifs. DNA sequence motifs in a single locus can be identical and/or heterogeneous. SSRs are encountered in many different branches of the prokaryote kingdom. They are found in genes encoding products as diverse as microbial surface components recognizing adhesive matrix molecules and specific bacterial virulence factors such as lipopolysaccharide-modifying enzymes or adhesins. SSRs enable genetic and consequently phenotypic flexibility. SSRs function at various levels of gene expression regulation. Variations in the number of repeat units per locus or changes in the nature of the individual repeat sequences may result from recombination processes or polymerase inadequacy such as slipped-strand mispairing (SSM), either alone or in combination with DNA repair deficiencies. These rather complex phenomena can occur with relative ease, with SSM approaching a frequency of 10 −4 per bacterial cell division and allowing high-frequency genetic switching. Bacteria use this random strategy to adapt their genetic repertoire in response to selective environmental pressure. SSR-mediated variation has important implications for bacterial pathogenesis and evolutionary fitness. Molecular analysis of changes in SSRs allows epidemiological studies on the spread of pathogenic bacteria. The occurrence, evolution and function of SSRs, and the molecular methods used to analyze them are discussed in the context of responsiveness to environmental factors, bacterial pathogenicity, epidemiology, and the availability of full-genome sequences for increasing numbers of microorganisms, especially those that are medically relevant.

13 February 2020 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
ABAlex Van Belkum
Alex Van Belkum
CBCarey-Ann D. Burnham
Carey-Ann D. Burnham
JRJohn W.A. Rossen
John W.A. Rossen
FMFrederic Mallard
Frederic Mallard
OROlivier Rochas
Olivier Rochas
WDWilliam Michael Dunne
William Michael Dunne

17 October 2018 in Nature Reviews Microbiology
Verified
Journal Article
Open access
PDF file
TTthe JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing
the JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing
ABAlex Van Belkum
Alex Van Belkum
TBTill T. Bachmann
Till T. Bachmann
GLGerd Lüdke
Gerd Lüdke
JLJan Gorm Lisby
Jan Gorm Lisby
WDWm. Michael Dunne
Wm. Michael Dunne
Antimicrobial susceptibility testing (AST) technologies help to accelerate the initiation of targeted antimicrobial therapy for patients with infections and could potentially extend the lifespan of current narrow-spectrum antimicrobials. Although conceptually new and rapid AST technologies have been described, including new phenotyping methods, digital imaging and genomic approaches, there is no single major, or broadly accepted, technological breakthrough that leads the field of rapid AST platform development. This might be owing to several barriers that prevent the timely development and implementation of novel and rapid AST platforms in health-care settings. In this Consensus Statement, we explore such barriers, which include the utility of new methods, the complex process of validating new technology against reference methods beyond the proof-of-concept phase, the legal and regulatory landscapes, costs, the uptake of new tools, reagent stability, optimization of target product profiles, difficulties conducting clinical trials and issues relating to quality and quality control, and present possible solutions.

18 November 2015 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
SHStephan Harbarth
Stephan Harbarth
HBHanan H. Balkhy
Hanan H. Balkhy
HGHerman Goossens
Herman Goossens
VJVincent Jarlier
Vincent Jarlier
JKJan Kluytmans
Jan Kluytmans
Didier PittetDidier Pittet
Didier Pittet
The lack of new antibiotic classes calls for a cautious use of existing agents. Yet, every 10 min, almost two tons of antibiotics are used around the world, all too often without any prescription or control. The use, overuse and misuse of antibiotics select for resistance in numerous species of bacteria which then renders antimicrobial treatment ineffective. Almost all countries face increased antimicrobial resistance (AMR), not only in humans but also in livestock and along the food chain. The spread of AMR is fueled by growing human and animal populations, uncontrolled contamination of fresh water supplies, and increases in international travel, migration and trade. In this context of global concern, 68 international experts attending the fifth edition of the World HAI Resistance Forum in June 2015 shared their successes and failures in the global fight against AMR. They underlined the need for a “One Health” approach requiring research, surveillance, and interventions across human, veterinary, agricultural and environmental sectors. This strategy involves concerted actions on several fronts. Improved education and increased public awareness are a well-understood priority. Surveillance systems monitoring infections need to be expanded to include antimicrobial use, as well as the emergence and spread of AMR within clinical and environmental samples. Adherence to practices to prevent and control the spread of infections is mandatory to reduce the requirement of antimicrobials in general care and agriculture. Antibiotics need to be banned as growth promoters for farm animals in countries where it has not yet been done. Antimicrobial stewardship programmes in animal husbandry have proved to be efficient for minimising AMR, without compromising productivity. Regarding the use of antibiotics in humans, new tools to provide highly specific diagnoses of pathogens can decrease diagnostic uncertainty and improve clinical management. Finally, infection prevention and control measures – some of them as simple as hand hygiene – are essential and should be extended beyond healthcare settings. Aside from regulatory actions, all people can assist in AMR reduction by limiting antibiotic use for minor illnesses. Together, we can all work to reduce the burden of AMR.

1 July 2001 in Clinical Microbiology Reviews
Verified
Journal Article
Open access
PDF file
ABAlex Van Belkum
Alex Van Belkum
MSMarc Struelens
Marc Struelens
AVArjan de Visser
Arjan de Visser
HVHenri Verbrugh
Henri Verbrugh
MTMichel Tibayrenc
Michel Tibayrenc
SUMMARY: Currently, genetic typing of microorganisms is widely used in several major fields of microbiological research. Taxonomy, research aimed at elucidation of evolutionary dynamics or phylogenetic relationships, population genetics of microorganisms, and microbial epidemiology all rely on genetic typing data for discrimination between genotypes. Apart from being an essential component of these fundamental sciences, microbial typing clearly affects several areas of applied microbiogical research. The epidemiological investigation of outbreaks of infectious diseases and the measurement of genetic diversity in relation to relevant biological properties such as pathogenicity, drug resistance, and biodegradation capacities are obvious examples. The diversity among nucleic acid molecules provides the basic information for all fields described above. However, researchers in various disciplines tend to use different vocabularies, a wide variety of different experimental methods to monitor genetic variation, and sometimes widely differing modes of data processing and interpretation. The aim of the present review is to summarize the technological and fundamental concepts used in microbial taxonomy, evolutionary genetics, and epidemiology. Information on the nomenclature used in the different fields of research is provided, descriptions of the diverse genetic typing procedures are presented, and examples of both conceptual and technological research developments for Escherichia coli are included. Recommendations for unification of the different fields through standardization of laboratory techniques are made.